Share Twitter LinkedIn Facebook Email Presented by Ajay K. Nooka, MD, MPH, FACP; Robert Z. Orlowski, MD, PhD; and Peter M. Voorhees, MD. Part 3 of 3 of a symposium recorded at an oncology specialty meeting.
FDA grants accelerated approval to ponatinib (ICLUSIG®) with chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia Acute Lymphoblastic Leukemia 3 Mins Read
FDA Approves Inotuzumab Ozogamicin (BESPONSA) for Acute Lymphoblastic Leukemia in Pediatric Patients [Exclusive Video] Acute Lymphoblastic Leukemia 3 Mins Read
Spotlight on CAR T-cell Therapy in 2024: Advances & Clinical Insights Acute Lymphoblastic Leukemia 3 Mins Read